跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SALBUTAMOL NEUTEC 2,5 MG SOLUCION PARA INHALACION POR NEBULIZADOR - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SALBUTAMOL NEUTEC 2,5 MG SOLUCION PARA INHALACION POR NEBULIZADOR
Approved
STANDARD
SALBUTAMOL NEUTEC 2,5 MG SOLUCION PARA INHALACION POR NEBULIZADOR
Neutec Inhaler Ireland Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 27, 2024
Approval ID
9616a032a676a3a9
Company
Neutec Inhaler Ireland Limited
Type
Standard
Approval Details
Approval Id
9616a032a676a3a9
Drug Cima Aemps Name
SALBUTAMOL NEUTEC 2,5 MG SOLUCION PARA INHALACION POR NEBULIZADOR
Register Number
89256
Holder Company Name
Neutec Inhaler Ireland Limited
Marketing Company Name
Neutec Inhaler Ireland Limited
Authorization Date
2024-03-27
Dosage Form
SOLUCIÓN PARA INHALACIÓN POR NEBULIZADOR
Dose
2,5 mg/2,5 ml
Route Of Administration
VÍA INHALATORIA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Neutec Inhaler Ireland Limited
Active Ingredients
SALBUTAMOL SULFATO
1,2 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 27, 2024
Approval ID
9616a032a676a3a9
Type
Standard
Back to CIMA-AEMPS Approvals